StockData
Pharvaris N.V. logo

Pharvaris N.V. (PHVS) stock

PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026Score 4/30
$31.55−0.73 (-2.26%)

Close on Nov 18, 2026Market cap $2.06BP/E –Yield –

Pharvaris free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -€137.24M. The highest annual figure on record is -€3.92M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€137.24M–
FY2024Dec 31, 2024-€120.67M–
FY2023Dec 31, 2023-€93.14M–
FY2022Dec 31, 2022-€67.29M–
FY2021Dec 31, 2021-€44.73M–
FY2020Dec 31, 2020-€21.54M–
FY2019Dec 31, 2019-€6.69M–
FY2018Dec 31, 2018-€3.92M–

More Pharvaris figures

See a number that looks wrong?